Selective Inhibition of Glioma Cells In Vivo via Low Intensity Ultrasound

Area of Science:

• Oncology
• Biophysics
• Medical Acoustics

Background:

• Cancer therapy faces challenges in selectively targeting malignant cells while sparing healthy tissues.
• Conventional treatments often result in collateral damage to normal cells, limiting efficacy.
• Developing non-invasive methods for selective cancer cell inhibition is a critical research area.

Purpose of the Study:

• To investigate the potential of low-intensity pulsed ultrasound (LIPUS) for selective cancer cell targeting.
• To determine specific LIPUS frequencies for inhibiting mouse and human glioma cells.
• To evaluate the efficacy and safety of LIPUS in preclinical glioma models.

Main Methods:

• Utilized low-intensity pulsed ultrasound (LIPUS) tuned to specific frequencies (0.3 MHz for mouse, 0.7 MHz for human glioma cells).
• Assessed cell viability in vitro for glioma cell lines and normal glial cell controls.
• Evaluated tumor growth inhibition and apoptosis induction in vivo using a subcutaneous xenograft mouse model.

Main Results:

• Tuned LIPUS significantly reduced glioma cell viability by over 25% in vitro (p < 0.001).
• Normal glial cells showed less than 5% viability reduction, indicating selectivity.
• LIPUS at 0.7 MHz inhibited human glioma tumor weight by 31.1% (p < 0.05) and induced apoptosis in vivo.

Conclusions:

• Frequency-tuned LIPUS demonstrates selective inhibition of both mouse and human glioma cells.
• This acoustically-driven approach offers a promising non-invasive strategy for glioma treatment.
• LIPUS presents a potential therapeutic option with minimal collateral damage to surrounding healthy brain tissue.